Loading clinical trials...
Loading clinical trials...
Phase II Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
Conditions
Interventions
18 F-DOPA
Locations
1
United States
Texas Children's Hospital
Houston, Texas, United States
Last Updated
September 7, 2020
NCT02021604
NCT04538989
NCT00674440
NCT01468454
NCT03042416
NCT03053284
Lead Sponsor
Baylor College of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions